Ist lavandula angustifolia callus extract in der Schwangerschaft sicher?
No EU Annex II/III listing for reproductive restriction or ban for Lavandula angustifolia callus extract, no harmonised CLP reproductive (H360/H361) or mutagenic/carcinogenic classification found, and no animal or human reproductive/developmental toxicity data identified for the callus extract in PubMed or regulatory dossiers. Available safety literature and CosIng list the ingredient as a cosmetic extract/INCI entry and recent peer‑reviewed work on the callus extract reports skin-recovery/Nrf2 activity, not reproductive effects (ECHA substance pages; CosIng/Official Journal; PubMed). ([echa.europa.eu](https://www.echa.europa.eu/substance-information/-/substanceinfo/100.081.783?utm_source=openai))
Related ingredients
Frequently asked questions
- Ist lavandula angustifolia callus extract in der Schwangerschaft sicher?
- No EU Annex II/III listing for reproductive restriction or ban for Lavandula angustifolia callus extract, no harmonised CLP reproductive (H360/H361) or mutagenic/carcinogenic classification found, and no animal or human reproductive/developmental toxicity data identified for the callus extract in PubMed or regulatory dossiers. Available safety literature and CosIng list the ingredient as a cosmetic extract/INCI entry and recent peer‑reviewed work on the callus extract reports skin-recovery/Nrf2 activity, not reproductive effects (ECHA substance pages; CosIng/Official Journal; PubMed). ([echa.europa.eu](https://www.echa.europa.eu/substance-information/-/substanceinfo/100.081.783?utm_source=openai))
- Ist lavandula angustifolia callus extract während des Stillens sicher?
- Same evidence base as for pregnancy: no harmonised reproductive or lactation hazards, no SCCS/CIR reproductive concerns located for this specific callus extract, and no published data showing placental or milk transfer for the callus extract. Ingredient is treated in regulatory databases as a botanical extract without reproductive classification. ([echa.europa.eu](https://www.echa.europa.eu/substance-information/-/substanceinfo/100.081.783?utm_source=openai))
- Ist lavandula angustifolia callus extract sicher für Babyhaut?
- Hazard and mechanism: no specific infant reproductive or developmental hazards identified for this callus extract. Exposure: topical botanical extracts commonly contain small lipophilic constituents (e.g., linalool/linalyl acetate reported for L. angustifolia essential oil) that are dermally bioavailable to a low degree in adults; infant skin has higher absorption — therefore adult exposure scored as low/measurable and infant exposure increased by +1 per instructions (adult e=1 → baby e=2). CosIng/ECHA list the extract as a cosmetic ingredient; EWG/EU allergen lists note allergenic constituents of lavender but not reproductive effects. ([boe.es](https://www.boe.es/doue/2019/121/L00001-00370.pdf?utm_source=openai))
- Wie bewertet VeriMom lavandula angustifolia callus extract?
- VeriMom bewertet lavandula angustifolia callus extract mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu lavandula angustifolia callus extract?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu lavandula angustifolia callus extract basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.